Order Article Reprints

Peindl M, Göttlich C, Crouch S, Hoff N, Lüttgens T, Schmitt F, Pereira JGN, May C, Schliermann A, Kronenthaler C, et al. EMT, Stemness, and Drug Resistance in Biological Context: A 3D Tumor Tissue/In Silico Platform for Analysis of Combinatorial Treatment in NSCLC with Aggressive KRAS-Biomarker Signatures. Cancers. 2022; 14(9):2176. https://doi.org/10.3390/cancers14092176

Peindl, Matthias, Claudia Göttlich, Samantha Crouch, Niklas Hoff, Tamara Lüttgens, Franziska Schmitt, Jesús Guillermo Nieves Pereira, Celina May, Anna Schliermann, Corinna Kronenthaler, and et al. 2022. "EMT, Stemness, and Drug Resistance in Biological Context: A 3D Tumor Tissue/In Silico Platform for Analysis of Combinatorial Treatment in NSCLC with Aggressive KRAS-Biomarker Signatures" Cancers 14, no. 9: 2176. https://doi.org/10.3390/cancers14092176

Peindl, M., Göttlich, C., Crouch, S., Hoff, N., Lüttgens, T., Schmitt, F., Pereira, J. G. N., May, C., Schliermann, A., Kronenthaler, C., Cheufou, D., Reu-Hofer, S., Rosenwald, A., Weigl, E., Walles, T., Schüler, J., Dandekar, T., Nietzer, S., & Dandekar, G. (2022). EMT, Stemness, and Drug Resistance in Biological Context: A 3D Tumor Tissue/In Silico Platform for Analysis of Combinatorial Treatment in NSCLC with Aggressive KRAS-Biomarker Signatures. Cancers, 14(9), 2176. https://doi.org/10.3390/cancers14092176